Showing results (71-80 of 126) with videos related to

Sort By:
Pageof 13
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 9, 2016
Risk of biochemical recurrence and timing of radiotherapy in pT3a N0 prostate cancer with positive surgical margin : A single center experienceNina-Sophie Hegemann, Sebastian Morcinek, Alexander Buchner, et al.
The Journal of Urology|June 29, 2021
Timing of Radiotherapy after Radical Prostatectomy: Effects on Health-Related Quality of LifeThilo Westhofen, Alexander Buchner, Boris Schlenker, et al.
World Journal of Urology|April 18, 2024
Health-related quality of life following salvage radical prostatectomy for recurrent prostate cancer after radiotherapy or focal therapySeverin Rodler, Dina Danninger, Lennert Eismann, et al.
Radiation and Environmental Biophysics|October 22, 2013
Current concepts in clinical radiation oncologyMichael Orth, Kirsten Lauber, Maximilian Niyazi, et al.
Radiation Oncology (London, England)|July 22, 2021
Dosimetric comparison of MR-linac-based IMRT and conventional VMAT treatment plans for prostate cancerVanessa Da Silva Mendes, Lukas Nierer, Minglun Li, et al.
Heliyon|October 25, 2022
Quality control, preparation process optimizing and anti-inflammatory effects of Premna Puberula Pamp. PectinKaiqi Liu, Yingying Guo, Xiaojing Chen, et al.
BMC Cancer|March 25, 2006
Small molecule receptor tyrosine kinase inhibitor of platelet-derived growth factor signaling (SU9518) modifies radiation response in fibroblasts and endothelial cellsMinglun Li, Gong Ping, Christian Plathow, et al.
Radiation Oncology (London, England)|March 13, 2016
Distribution of prostate nodes: a PET/CT-derived anatomic atlas of prostate cancer patients before and after surgical treatmentNina-Sophie Hegemann, Vera Wenter, Sonja Spath, et al.
Radiation Oncology (London, England)|March 22, 2021
Radiotherapy of oligometastatic prostate cancer: a systematic reviewPaul Rogowski, Mack Roach, Nina-Sophie Schmidt-Hegemann, et al.
Translational Lung Cancer Research|July 18, 2020
Maximum standardized uptake value of primary tumor (SUVmax_PT) and horizontal range between two most distant PET-positive lymph nodes predict patient outcome in inoperable stage III NSCLC patients after chemoradiotherapyOlarn Roengvoraphoj, Lukas Käsmann, Chukwuka Eze, et al.
Pageof 13